CE20 - Biologie des animaux, des organismes photosynthétiques et des micro-organismes 2022

Phenotypic heterogeneity and host adaptation during stationary phase in sporulating pathogenic Firmicutes – PHHASt

Submission summary

Pathogenic bacteria must constantly adapt to environmental changes during infection. Our results show that the entomopathogenic bacterium Bacillus thuringiensis has developed an alternative to sporulation to survive in the host cadaver. This study, focused on bacteria of the Bacillus cereus group, pathogenic to humans and animals, aims to characterize this state, which has been obscured by sporulation, considered for a long time as the only survival strategy in spore-forming firmicutes. Our objective is to characterize the regulatory networks underlying this physiological state by implementing complementary global and targeted methods at the population and cellular level, using molecular biology, flow cytometry, an animal model and bioinformatics analyses. This project will allow the understanding of a new mechanism leading to phenotypic heterogeneity allowing bacteria to persist in their niche and potentially adapt more rapidly to environmental changes. This research could open new perspectives for the control of spore-forming pathogenic bacteria.

Project coordination

Leyla Slamti (Institut national de recherche pour l'agriculture, l'alimentation et l'environnement)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partnership

MaIAGE Institut national de recherche pour l'agriculture, l'alimentation et l'environnement
MICALIS Institut national de recherche pour l'agriculture, l'alimentation et l'environnement
IRBA Ministère de la défense

Help of the ANR 446,293 euros
Beginning and duration of the scientific project: October 2022 - 42 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter